Phreesia PHR shares rose by 13.9%, closing at $21.19 in the last trading session. This increase was accompanied by significant trading volume, indicating strong investor interest. In contrast, the stock had experienced a 12.9% decline over the previous four weeks.
The notable price rise reflects investors’ optimism as Phreesia prepares to release its fiscal 2025 third-quarter results on Dec. 9, after market close. In the second quarter, the company achieved an important milestone by posting positive free cash flow, marking a new strategy to use internally generated funds for enhancing stakeholder value.
For its upcoming report, Phreesia is expected to report a quarterly loss of $0.29 per share, an improvement of 50% compared to last year. Revenues are projected at $106 million, representing an increase of 15.7% from the same quarter a year ago.
While expectations for earnings and revenue growth provide insight into a stock’s potential, research indicates that trends in earnings estimate revisions significantly correlate with stock price movements. For Phreesia, the consensus EPS estimate has remained steady over the last month. Typically, a stock’s price does not consistently rise without some momentum in earnings estimate revisions. Investors should monitor PHR to see if this recent gain can lead to sustained strength.
Currently, the stock holds a Zacks Rank #2 (Buy). For those interested, a complete list of today’s Zacks Rank #1 (Strong Buy) stocks is available here >>>>
Part of the Zacks Medical Info Systems sector, P3 Health Partners Inc. PIII also saw positive movement, closing 5.4% higher at $0.37, though it has slipped 3% over the past month.
P3 Health Partners’ consensus EPS estimate remains unchanged at -$0.03 over the month, marking a 75% improvement compared to last year’s figures. The company holds a Zacks Rank of #3 (Hold).
Unveiling the Future of Energy: Nuclear Power
The global need for electricity is rapidly increasing, leading us to seek alternatives to fossil fuels like oil and natural gas. Nuclear energy presents a viable solution.
Recently, leaders from the US and 21 other nations pledged to triple global nuclear energy capacity. This transformative phase could yield significant returns for nuclear-related stocks, particularly for early investors.
Our latest report, Atomic Opportunity: Nuclear Energy’s Comeback, highlights the key players and technologies set to drive this resurgence, including three standout stocks that are positioned for tremendous benefits.
Download Atomic Opportunity: Nuclear Energy’s Comeback for free today.
Interested in the latest stock recommendations from Zacks Investment Research? You can download 5 Stocks Set to Double free of charge. Click to access this report.
Phreesia, Inc. (PHR) : Free Stock Analysis Report
P3 Health Partners Inc. (PIII) : Free Stock Analysis Report
To read this article on Zacks.com, click here.
Zacks Investment Research
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
